Fundraise / allotmentNotableFiled on BSE ·

Niva Bupa approves Q1 2026 financials and plans ₹500 crore NCD issuance

Niva Bupa Health Insurance Company · Insurance

Arthneeti Research DeskPublished 1 min read
₹500 CrFundraise / allotment

Key highlights

  • Board approved unaudited financial results for quarter ended June 30, 2026; joint auditors issued limited review report on July 30, 2026
  • Board approved fund raise via private placement of up to ₹500 crore unsecured, subordinated, redeemable, rated, non-convertible debentures
  • Debt Raising Committee constituted to finalize terms/conditions; details to be disclosed later; meeting held July 30, 2026 from 3:00-3:45 PM IST

Why it's rated notable: amount is ₹500 crore or more

Original filing

Board Meeting Outcome for Outcome Of Board Meeting Held On July 30, 2026

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Niva Bupa Health Insurance Company

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.